Fundz
Back to SEC Filings
10-QMEDIUM RiskDETERIORATING

VivoSim Labs, INC.

vivosim.ai
Filed: Feb 11, 2026 CIK: 0001497253Biotechnology
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

VivoSim Labs shows severe financial deterioration with cash declining 62% to $4.3M, stockholders' equity collapsing 58% to $4.4M, and minimal revenue of just $91K over nine months. The company is burning cash rapidly with $8.3M operating losses against negligible revenues, indicating potential viability concerns.

Red Flags Detected (7)

Cash and cash equivalents declined 62% from $11.3M to $4.3M in 9 months

Stockholders' equity collapsed 58% from $10.5M to $4.4M

Accumulated deficit increased to $350.2M with $8.1M net loss in 9 months

4 more red flags detected

Key Takeaways

Company raised $1.8M through public offering but cash continues declining rapidly

Revenue growth minimal - royalty revenue increased only $23K year-over-year

3 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateFeb 11, 2026
Risk LevelMEDIUM
TrendDETERIORATING
AI Confidence85%
Red Flags7

What This Means

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings